Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ada68032e6c5599de33d868231aaa52d |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-17 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0053 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-10 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-17 |
filingDate |
2016-08-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2f8ce5cc086a9587d804ce5c03bed49a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_86308851907047fda1cb3f5af9c68190 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_27939f7469a7715ee9f4e6febe197b2e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ea845673c72da372d3783331d4251879 |
publicationDate |
2018-03-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
TW-201806589-A |
titleOfInvention |
Pharmaceutical composition for treating osteoporosis |
abstract |
The invention provides the use of a compound of formula I for the manufacture of a pharmaceutical composition for the treatment of osteoporosis, wherein the pharmaceutical composition comprises the compound of formula I or a pharmaceutically acceptable salt thereof. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113786397-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113786397-B |
priorityDate |
2016-08-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |